Sanofi (BIT:1SAN)

Italy flag Italy · Delayed Price · Currency is EUR
86.07
-1.24 (-1.42%)
Last updated: Jun 2, 2025
-4.01%
Market Cap 105.71B
Revenue (ttm) 45.17B
Net Income (ttm) 6.30B
Shares Out n/a
EPS (ttm) 5.04
PE Ratio 16.78
Forward PE 10.88
Dividend 3.92 (4.55%)
Ex-Dividend Date May 12, 2025
Volume 1,766
Average Volume 2,329
Open 94.90
Previous Close 87.31
Day's Range 85.90 - 94.90
52-Week Range 85.14 - 111.00
Beta 0.43
RSI 34.99
Earnings Date Jul 31, 2025

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; inf... [Read more]

Sector Healthcare
Founded 1994
Employees 82,878
Stock Exchange Borsa Italiana
Ticker Symbol 1SAN
Full Company Profile

Financial Performance

In 2024, Sanofi's revenue was 44.29 billion, an increase of 7.73% compared to the previous year's 41.11 billion. Earnings were 5.56 billion, an increase of 2.96%.

Financial Statements

News

There is no news available yet.